External factors
| External factors: |
Pravastatin |
| Category: |
Chemical compounds |
| Cell name: |
Endothelial cell |
| Experiment: |
SA-β-gal activity assay//BrdU assay |
| Description: |
Treatment with atorvastatin, pravastatin, or pitavastatin inhibited the senescent phenotype at 10 days.In parallel with this, an increased rate of 5-bromodeoxyuridine (BrdU) (index of proliferation) incorporation and telomerase activity were restored by treatment with atorvastatin, pravastatin, and pitavastatin. |
Warning: Undefined variable $target_genes in
/data/html/Aging-ReG/public/browse_detail_2.php on line
385
Warning: Trying to access array offset on null in
/data/html/Aging-ReG/public/browse_detail_2.php on line
383
Regulatory relationship
| R-EF-Target gene:
|
Upregulation//Activation |
| Official symbol(s): |
SIRT1//ENOS |
| Target gene experiment: |
Western blot |
| Target gene description: |
In the presence of H2O2, treatment with atorvastatin, pravastatin, and pitavastatin increased eNOS expression dose dependently. In parallel with eNOS expression, activity of eNOS was increased by treatment with atorvastatin,We found that atorvastatin, pravastatin, and pitavastatin significantly increased SIRT1 expression in a concentration-dependent manner for 10 days after treatment with H2O2. |
| Official symbol(s): |
Warning: Undefined variable $name_all in /data/html/Aging-ReG/public/browse_detail_2.php on line 525
AKT1
|
| Pathway experiment: |
Western blot |
| Pathway description: |
Treatment with atorvastatin, pravastatin, or pitavastatin increased the phosphorylation of Akt at Ser473. |
Aging network
Annotation:
The green line represents Upregulation.
The purple line represents Downregulation.
The orange line represents Activation.
The yellow line represents Inhibition.
The gray line represents Unclear.